Nivolumab 40mg Injection
Marketer
Oro Pharmaceuticals Pvt Ltd
Salt Composition
Nivolumab (40mg)
Overview Nivolumab 40mg Injection
Nivolumab 40mg, administered intravenously by a healthcare professional, treats various cancers including non-small cell lung, kidney, head and neck, melanoma, Hodgkin's lymphoma, and liver cancer. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; improper use can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include skin rash, fatigue, headache, and pyrexia. Serious infusion-related reactions such as rigors, pruritus, erythema, flushing, dyspnea, and vertigo necessitate close post-infusion monitoring for allergic responses. Prior to treatment, disclose any pre-existing pulmonary, hepatic, or renal conditions, and all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout the treatment period.
Uses of Nivolumab 40mg Injection
Lung cancer (excluding small cell type), renal cell carcinoma, cancers of the head and neck, cutaneous melanoma, Hodgkin lymphoma, and hepatocellular carcinoma.
Major Benefits of Nivolumab 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Nivolumab 40mg Injection:
- Rash
- Weakness
- Headache
- Fever
- Musculoskeletal (bone, muscle or joint) pain
- Back pain
- Stomach pain
- Nausea
- Itching
- Constipation
- Diarrhea
- Upper respiratory tract infection
- Decreased appetite
- Breathlessness
- Cough
How to use Nivolumab 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Nivolumab 40mg Injection works:
Nivolumab, administered as a 40mg injection, combats cancer by inhibiting the PD-1 protein found on T lymphocytes. This blockade unleashes the T-cells, enabling them to target and destroy cancerous cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Nivolumab 40mg Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering 40mg of nivolumab intravenously is contraindicated during pregnancy due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Administration of 40mg Nivolumab Injection while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 40mg injection of nivolumab.
KidneySAFE IF PRESCRIBED
Nivolumab 40mg Injection presents a safe treatment option for individuals with impaired kidney function. No alteration of the Nivolumab 40mg Injection dosage is necessary.
LiverSAFE IF PRESCRIBED
For patients with hepatic impairment, the 40mg Nivolumab injection presents a safe treatment option. No alteration to the 40mg Nivolumab injection dosage is advised.
What if you forget to take Nivolumab 40mg Injection :
NA
Facts to Know About Nivolumab 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | PD-1 Checkpoint Blockade |
3,018 People bought this recently